Refine
Has Fulltext
- yes (21)
Is part of the Bibliography
- yes (21)
Year of publication
Document Type
- Journal article (20)
- Preprint (1)
Language
- English (21) (remove)
Keywords
- caloric restriction (4)
- mass spectrometry (4)
- LC/MS (3)
- NRF2 (3)
- methionine restriction (3)
- ATF4 (2)
- CSF (2)
- L929 (2)
- MYC (2)
- amino acid (2)
- biomarker (2)
- cerebrospinal fluid (2)
- forensic neuropathology (2)
- forensic neurotraumatology (2)
- liquid chromatography/mass spectrometry (2)
- melanoma (2)
- metabolism (2)
- metabolomics (2)
- 2-DG (1)
- 2-deoxy-D-glucose (1)
- AMP-activated protein kinase (AMPK) (1)
- Beige adipocytes (1)
- C/EBP (1)
- CHAC1 (1)
- COX2 expression (1)
- CRISPR-Cas9 (1)
- Chlamydia trachomatis (1)
- CoA (1)
- GSH (1)
- HUWE1 (1)
- IL-4 antagonists (1)
- Interleukin-4 (IL-4) (1)
- JUN (1)
- MIZ1 (1)
- NAD (1)
- Protein kinase D1 (PKD1) (1)
- Protein kinase D3 (PKD3) (1)
- SLC7A11 (1)
- activity-based probes (1)
- amino acid analogues (1)
- amino acid restriction (1)
- antagonist (1)
- arginine metabolism (1)
- atopic diseases (1)
- autophagy (1)
- biofluid (1)
- biology (1)
- biosynthetic glycosylation (1)
- cancer (1)
- cancer therapy (1)
- cathepsin (1)
- chemical glycosylation (1)
- cholesterol (1)
- colorectal cancer (1)
- contact inhibition (1)
- crotonase (1)
- crystal structure (1)
- cysteine restriction (1)
- cysteine synthase inhibitor (1)
- cytotoxic T cells (1)
- dehydrogenase (1)
- diacylglycerol (DAG) (1)
- digestive system (1)
- drug discovery (1)
- energy restriction (1)
- glioblastoma (1)
- glucose restriction (1)
- glycoengineering (1)
- glycolytic flux control (1)
- growth and differentiation factor 5 (1)
- homocysteine (1)
- infection (1)
- inflammation (1)
- integrated stress response (1)
- intrinsic metabolism (1)
- ligand-receptor complex (1)
- lipid metabolism (1)
- liver (1)
- low carb (1)
- lung cancer (1)
- lymphocyte differentiation (1)
- lysosome (1)
- melanoma malignancy (1)
- metabolome (1)
- methionine (1)
- monolayer (1)
- mouse model (1)
- neurospheres (1)
- non-small cell lung cancer (1)
- perfusion culture (1)
- pharmacology (1)
- phosphoglycolate phosphatase (1)
- proliferation (1)
- substrate channeling (1)
- thiol starvation (1)
- transcriptome (1)
- translational research (1)
- tumor-associated macrophage (1)
- ubiquitination (1)
- β3 adrenergic receptor (ADRB3) (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (21)
- Rudolf-Virchow-Zentrum (6)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (5)
- Pathologisches Institut (4)
- Comprehensive Cancer Center Mainfranken (2)
- Institut für Rechtsmedizin (2)
- Julius-von-Sachs-Institut für Biowissenschaften (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Pharmakologie und Toxikologie (1)
Schriftenreihe
EU-Project number / Contract (GA) number
- 678119 (2)
- 260464 (1)
- ERC-2018-ADG/NCI-CAD (1)
In the last few years, quantitative analysis of metabolites in body fluids using LC/MS has become an established method in laboratory medicine and toxicology. By preparing metabolite profiles in biological specimens, we are able to understand pathophysiological mechanisms at the biochemical and thus the functional level. An innovative investigative method, which has not yet been used widely in the forensic context, is to use the clinical application of metabolomics. In a metabolomic analysis of 41 samples of postmortem cerebrospinal fluid (CSF) samples divided into cohorts of four different causes of death, namely, cardiovascular fatalities, isoIated torso trauma, traumatic brain injury, and multi-organ failure, we were able to identify relevant differences in the metabolite profile between these individual groups. According to this preliminary assessment, we assume that information on biochemical processes is not gained by differences in the concentration of individual metabolites in CSF, but by a combination of differently distributed metabolites forming the perspective of a new generation of biomarkers for diagnosing (fatal) TBI and associated neuropathological changes in the CNS using CSF samples.